000298577 001__ 298577
000298577 005__ 20250316015611.0
000298577 0247_ $$2doi$$a10.1016/j.canep.2025.102760
000298577 0247_ $$2pmid$$apmid:39904714
000298577 0247_ $$2ISSN$$a1877-7821
000298577 0247_ $$2ISSN$$a1877-783X
000298577 0247_ $$2altmetric$$aaltmetric:174398632
000298577 037__ $$aDKFZ-2025-00294
000298577 041__ $$aEnglish
000298577 082__ $$a610
000298577 1001_ $$aChen, Jintu$$b0
000298577 245__ $$aGlobal epidemiological trends of trachea, bronchus, and lung cancer in the elderly.
000298577 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2025
000298577 3367_ $$2DRIVER$$aarticle
000298577 3367_ $$2DataCite$$aOutput Types/Journal article
000298577 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1741680589_25289
000298577 3367_ $$2BibTeX$$aARTICLE
000298577 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000298577 3367_ $$00$$2EndNote$$aJournal Article
000298577 500__ $$a2025 Apr;95:102760
000298577 520__ $$aDespite most patients with trachea, bronchus, and lung (TBL) cancer being elderly, epidemiological data specific to this population remain scarce. This study aims to update and delineate the global epidemiological profile of TBL in older adults.An analysis was conducted on data from the Global Burden of Diseases (GBD) 2021 for individuals aged 60 and older. We evaluated the worldwide impact of TBL cancer by socio-demographic index (SDI), gender, and age across 204 countries and territories, including their spatial and temporal trends. The main outcomes comprised age-standardized incidence rates (ASIR), mortality rates (ASMR), disability-adjusted life years (DALY) rates (ASDR), and average annual percent change (AAPC).From 1992 to 2021, the estimated cases of TBL cancer, along with associated deaths and DALYs, increased among the elderly. The ASIR, ASMR, and ASDR all exhibited a declining trend. In 2021, East Asia faced a substantial TBL cancer burden, whereas Western Sub-Saharan Africa exhibited a notable increase over the last thirty years. In 2021, Monaco and Greenland recorded the highest ASIR, ASMR, and ASDR, while Egypt experienced the most significant rise in these rates from 1992 to 2021. The greatest affected age group was those aged 85-89. The TBL cancer burden followed distinct patterns by SDI and sex, with higher SDI regions and females facing a particularly notable increase in burden. From 1992 to 2021, smoking was the leading risk factor for TBL cancer-related deaths and DALYs in older adults, with particulate matter air pollution as a close second.The burden of TBL cancer varies widely across different regions and demographics. More attention should be paid to the elderly in higher SDI regions and females. Recognizing these trends is crucial for enhancing tertiary prevention strategies for TBL cancer and exploring innovative approaches to diagnosis and treatment.
000298577 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000298577 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000298577 650_7 $$2Other$$aEpidemiology
000298577 650_7 $$2Other$$aHealth disparities
000298577 650_7 $$2Other$$aRisk factors
000298577 650_7 $$2Other$$aThe elderly
000298577 650_7 $$2Other$$aTrachea, bronchus, and lung cancer
000298577 7001_ $$aLi, Caili$$b1
000298577 7001_ $$aYu, Yang$$b2
000298577 7001_ $$aLiu, Shanghai$$b3
000298577 7001_ $$0P:(DE-He78)37890b29d23d511bbcc2a2fdf82ebe8d$$aHu, Qipeng$$b4$$udkfz
000298577 7001_ $$aCai, Chengzhi$$b5
000298577 7001_ $$aLuo, Jieyan$$b6
000298577 7001_ $$aWu, Yijun$$b7
000298577 7001_ $$aTu, Zegui$$b8
000298577 773__ $$0PERI:(DE-600)2498032-8$$a10.1016/j.canep.2025.102760$$gp. 102760 -$$p102760$$tCancer epidemiology$$v95$$x1877-7821$$y2025
000298577 909CO $$ooai:inrepo02.dkfz.de:298577$$pVDB
000298577 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)37890b29d23d511bbcc2a2fdf82ebe8d$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000298577 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000298577 9141_ $$y2025
000298577 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEMIOL : 2022$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-16
000298577 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-16
000298577 9201_ $$0I:(DE-He78)D400-20160331$$kD400$$lPathologie infektionsbedingter Tumoren$$x0
000298577 980__ $$ajournal
000298577 980__ $$aVDB
000298577 980__ $$aI:(DE-He78)D400-20160331
000298577 980__ $$aUNRESTRICTED